| Literature DB >> 25458842 |
Chendong Yang1, Bookyung Ko1, Christopher T Hensley1, Lei Jiang1, Ajla T Wasti2, Jiyeon Kim1, Jessica Sudderth1, Maria Antonietta Calvaruso1, Lloyd Lumata3, Matthew Mitsche4, Jared Rutter5, Matthew E Merritt3, Ralph J DeBerardinis6.
Abstract
Alternative modes of metabolism enable cells to resist metabolic stress. Inhibiting these compensatory pathways may produce synthetic lethality. We previously demonstrated that glucose deprivation stimulated a pathway in which acetyl-CoA was formed from glutamine downstream of glutamate dehydrogenase (GDH). Here we show that import of pyruvate into the mitochondria suppresses GDH and glutamine-dependent acetyl-CoA formation. Inhibiting the mitochondrial pyruvate carrier (MPC) activates GDH and reroutes glutamine metabolism to generate both oxaloacetate and acetyl-CoA, enabling persistent tricarboxylic acid (TCA) cycle function. Pharmacological blockade of GDH elicited largely cytostatic effects in culture, but these effects became cytotoxic when combined with MPC inhibition. Concomitant administration of MPC and GDH inhibitors significantly impaired tumor growth compared to either inhibitor used as a single agent. Together, the data define a mechanism to induce glutaminolysis and uncover a survival pathway engaged during compromised supply of pyruvate to the mitochondria.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25458842 PMCID: PMC4268166 DOI: 10.1016/j.molcel.2014.09.025
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970